Concepedia

Multiple Endpoint Adjustment

Multiple Endpoint Adjustment is a statistical methodology within the broader class of multiple comparison procedures that specifically addresses the inflation of Type I error rates arising from the simultaneous evaluation of multiple outcome measures or endpoints in a single study.

20

Publications

1.5K

Citations

68

Authors

50

Institutions

Publications per year

2017–2026

1

Variants

Multiple Endpoint Correction

Parents

Publications

20

Multiplicity in randomised trials I: endpoints and treatments

Kenneth F. Schulz, David A. Grimes · The Lancet · 2005 · 373 citations

, , +8

Practical Guidelines for Multiplicity Adjustment in Clinical Trials

Michael A. Proschan, Myron A. Waclawiw · Controlled Clinical Trials · 2000 · 226 citations

, , +11

Some statistical methods for multiple endpoints in clinical trials

Ji Zhang, Hui Quan, Jennifer Ng et al. · Controlled Clinical Trials · 1997 · 171 citations

, , +14

Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America

Walter Offen, Christy Chuang‐Stein, Alex Dmitrienko et al. · Drug Information Journal · 2007 · 125 citations · Full text

, , +14

Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues

Abdul J. Sankoh, Ralph B. D’Agostino, Mohammad F. Huque · Statistics in Medicine · 2003 · 110 citations

, , +16

1–5 of 20

Authors

68

  1. AJ
    Abdul J. Sankoh

    Sage Therapeutics (United States), United States

    3 publications · 256 citations

    3

    h-index

  2. MF
    Mohammad F. Huque

    Office of Science, United States

    2 publications · 131 citations

    2

    h-index

  3. HQ
    Hui Quan

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    2 publications · 191 citations

    2

    h-index

  4. RB
    Ralph B. D’Agostino

    Boston University, United States

    2 publications · 131 citations

    2

    h-index

  5. AK
    Alok Krishen

    Research Triangle Park Foundation, United States

    2 publications · 188 citations

    2

    h-index

1–5 of 68

Institutions

50

  1. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    2 h-index

    5 publications

    704 citations

  2. Boston University

    Boston, United States

    2 h-index

    3 publications

    152 citations

  3. Procter & Gamble (United States)

    Cincinnati, United States

    1 h-index

    1 publications

    125 citations

  4. National Heart Lung and Blood Institute

    Bethesda, United States

    1 h-index

    1 publications

    226 citations

  5. Bridge Pharma (United States)

    Sarasota, United States

    1 h-index

    1 publications

    110 citations

  6. The University of Queensland

    Brisbane, Australia

    1 h-index

    1 publications

    24 citations

  7. Charité - Universitätsmedizin Berlin

    Berlin, Germany

    1 h-index

    1 publications

    15 citations

  8. Corporation for Public Broadcasting

    Washington D.C., United States

    1 h-index

    1 publications

    110 citations

1–8 of 50

Venues

  1. Statistics in Medicine

    7 publications · 398 citations

    7

    h-index

  2. Controlled Clinical Trials

    3 publications · 427 citations

    3

    h-index

  3. Drug Information Journal

    DIA · 2 publications · 146 citations

    2

    h-index

  4. Global Cardiology

    1 publications · 15 citations

    1

    h-index

  5. Computational Statistics & Data Analysis

    CSDA · 1 publications · 15 citations

    1

    h-index

1–5